{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:29:50Z","timestamp":1791300590374,"version":"4.1.0"},"reference-count":175,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Coutinho MF","award":["SFRH\/BPD\/101965\/2014"],"award-info":[{"award-number":["SFRH\/BPD\/101965\/2014"]}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ymgme.2015.08.008","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T18:02:43Z","timestamp":1439920963000},"page":"53-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["From rare to common and back again: 60years of lysosomal dysfunction"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2222-3622","authenticated-orcid":false,"given":"Maria Francisca","family":"Coutinho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8881-9197","authenticated-orcid":false,"given":"Sandra","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2015.08.008_bb0245","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1042\/bj0600604","article-title":"Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue","volume":"60","author":"de Duve","year":"1955","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0460","series-title":"Gaucher Disease: A Century of Delineation and Research","first-page":"177","article-title":"The pathology of Gaucher disease","author":"Lee","year":"1982"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0870","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/ajh.24057","article-title":"Gaucher disease and comorbidities: B-cell malignancy and parkinsonism","volume":"90","author":"Cox","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0725","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0420","first-page":"31","article-title":"Adult GM2 gangliosidosis masquerading as slowly progressive muscular atrophy: motor neuron disease phenotype","volume":"1","author":"Jellinger","year":"1982","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0665","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/jnnp.62.6.622","article-title":"[18F]fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosis","volume":"62","author":"Ruottinen","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0025","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1212\/WNL.54.5.1069","article-title":"Decreased striatal dopamine transporter density in JNCL patients with parkinsonian symptoms","volume":"54","author":"Aberg","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0565","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/mds.10104","article-title":"Autosomal dominant adult neuronal ceroid lipofuscinosis: parkinsonism due to both striatal and nigral dysfunction","volume":"17","author":"Nijssen","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0680","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jnen\/63.4.323","article-title":"Aberrant phosphorylation of alpha-synuclein in human Niemann\u2013Pick type C1 disease","volume":"63","author":"Saito","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0760","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00401-007-0264-z","article-title":"Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses","volume":"114","author":"Suzuki","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0385","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00401-007-0325-3","article-title":"Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue","volume":"115","author":"Hamano","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0710","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/mds.23774","article-title":"Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond","volume":"26","author":"Shachar","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0740","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/brain\/awu002","article-title":"Glucocerebrosidase is shaking up the synucleinopathies","volume":"137","author":"Siebert","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0345","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.beem.2014.08.009","article-title":"Bridging the age spectrum of neurodegenerative storage diseases","volume":"29","author":"Boland","year":"2015","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10545-010-9075-9","article-title":"Pathophysiology of neuropathic lysosomal storage disorders","volume":"33","author":"Bellettato","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0240","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.ph.28.030166.002251","article-title":"Functions of lysosomes","volume":"28","author":"de Duve","year":"1966","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0640","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbamcr.2008.12.022","article-title":"Delivery of endocytosed membrane proteins to the lysosome","volume":"1793","author":"Pryor","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0790","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0300-9084(03)00047-6","article-title":"Salvage pathways in glycosphingolipid metabolism","volume":"85","author":"Tettamanti","year":"2003","journal-title":"Biochimie"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0775","first-page":"55","article-title":"Symmetrical changes in the region of the yellow spot in each eye of na infant","volume":"1","author":"Tay","year":"1881","journal-title":"Trans. Ophthalmol. Soc. U. K."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0670","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00005053-188709000-00001","article-title":"On arrested cerebral development with special reference to cortical pathology","volume":"14","author":"Sachs","year":"1887","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0335","series-title":"De l'epithelioma primitif de la rate","author":"Gaucher","year":"1882"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0290","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01986897","article-title":"Ein Beitrag zur Kenntniss der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebrae)","volume":"43","author":"Fabry","year":"1898","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0560","first-page":"1","article-title":"Ein unbekanntes Krankheitsbild","volume":"79","author":"Niemann","year":"1914","journal-title":"Jahrb. Kinderheilkd."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0605","first-page":"519","article-title":"Der Morbus Gaucher und die ihm \u00e4hnlichen Krankheiten (die lipoidzellige Splenohepatomegalie Typus Niemann und die diabetische Lipoidzellenhypoplasie der Milz)","volume":"29","author":"Pick","year":"1926","journal-title":"Ergeb. Inn. Med. Kinderheilkd. (Berl.)"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0620","first-page":"304","article-title":"Over idiopatische hypertropie van het hart","volume":"76","author":"Pompe","year":"1932","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0400","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/bj0860011","article-title":"Alpha-glucosidase deficiency in generalized glycogen storage disease (Pompe's disease)","volume":"86","author":"Hers","year":"1963","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0080","first-page":"1139","article-title":"An electron microscopic and biochemical study of type II glycogenosis","volume":"13","author":"Baudhuin","year":"1964","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0250","series-title":"Lysosomal Storage Disorders","first-page":"1","article-title":"From lysosomes to storage diseases and back: a personal reminiscence","author":"de Duve","year":"2007"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0405","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0016-5085(65)80041-5","article-title":"Inborn lysosomal diseases","volume":"48","author":"Hers","year":"1965","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0805","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1432-1033.1968.tb19570.x","article-title":"The abnormalities of lysosomal enzymes in mucopolysacccharidoses","volume":"7","author":"Van Hoof","year":"1968","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0135","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1056\/NEJM196608112750606","article-title":"The sphingolipidoses","volume":"275","author":"Brady","year":"1966","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0130","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1073\/pnas.55.2.366","article-title":"The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann\u2013Pick disease","volume":"55","author":"Brady","year":"1966","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0310","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1073\/pnas.60.2.699","article-title":"The defect in Hurler's and Hunter's syndromes: faulty degradation of mucopolysaccharide","volume":"60","author":"Fratantoni","year":"1968","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0395","series-title":"Lysosomes and Storage Diseases","year":"1973"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0075","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbamcr.2008.12.001","article-title":"Lysosomal disorders: from storage to cellular damage","volume":"1793","author":"Ballabio","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0700","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tins.2011.05.006","article-title":"Clarifying lysosomal storage diseases","volume":"34","author":"Schultz","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0590","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1152\/physiol.00041.2009","article-title":"Lysosomal storage disease: revealing lysosomal function and physiology","volume":"25","author":"Parkinson-Lawrence","year":"2010","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0860","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/siny.2001.0088","article-title":"Lysosomal disorders","volume":"7","author":"Wraith","year":"2002","journal-title":"Semin. Neonatol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0315","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrm1423","article-title":"The cell biology of lysosomal storage disorders","volume":"5","author":"Futerman","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0815","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2141.2004.05293.x","article-title":"Lysosomal storage disorders","volume":"128","author":"Vellodi","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0825","doi-asserted-by":"crossref","first-page":"20423","DOI":"10.1074\/jbc.R110.134452","article-title":"Common and uncommon pathogenic cascades in lysosomal storage diseases","volume":"285","author":"Vitner","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0110","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0800","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/10408360390247832","article-title":"Carrier testing for autosomal-recessive disorders","volume":"40","author":"Vallance","year":"2003","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0065","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-0404.1993.tb04114.x","article-title":"Epileptic seizures in aspartylglucosaminuria: a common disorder","volume":"87","author":"Arvio","year":"1993","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0685","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0387-7604(88)80075-5","article-title":"Neuronal ceroid-lipofuscinoses in childhood","volume":"10","author":"Santavuori","year":"1988","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0625","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0505","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0615","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","article-title":"Prevalence of lysosomal storage diseases in Portugal","volume":"12","author":"Pinto","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0630","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10545-010-9093-7","article-title":"The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations","volume":"33","author":"Poupetov\u00e1","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0835","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10545-008-1040-5","article-title":"Pathogenic cascades in lysosomal disease\u2014why so complex?","volume":"32","author":"Walkley","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0830","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbamcr.2008.11.014","article-title":"Secondary lipid accumulation in lysosomal disease","volume":"1793","author":"Walkley","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0295","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1479-7364-5-3-156","article-title":"Lysosomal storage disorders: molecular basis and laboratory testing","volume":"5","author":"Filocamo","year":"2011","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0845","series-title":"Lysosomal Storage Disorders \u2014 A Practical Guide","first-page":"37","article-title":"Classification of lysosomal storage diseases","author":"Winchester","year":"2012"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0305","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1073\/pnas.64.1.360","article-title":"The defect in Hurler and Hunter syndromes. II. Deficiency of specific factors involved in mucopolysaccharide degradation","volume":"64","author":"Fratantoni","year":"1969","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0215","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ymgme.2011.12.012","article-title":"Mannose-6-phosphate pathway: a review on its role in lysosomal function and dysfunction","volume":"105","author":"Coutinho","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0220","series-title":"Lysosomal Storage Disorders \u2014 A Practical Guide","first-page":"153","article-title":"Current treatments","author":"Cox","year":"2012"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0350","series-title":"Lysosomal Storage Disorders \u2014 A Practical Guide","first-page":"94","article-title":"The mucopolysaccharidoses","author":"Giugliani","year":"2012"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0125","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrneurol.2013.163","article-title":"Lysosomal storage diseases\u2014the horizon expands","volume":"9","author":"Boustany","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0820","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2015.0754","article-title":"Inborn errors of metabolism: advances in diagnosis and therapy","author":"Vernon","year":"2015","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0375","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1517\/14712598.2011.582036","article-title":"Gene therapy for lysosomal storage disorders","volume":"11","author":"Gritti","year":"2011","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0085","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1517\/14728214.2010.498580","article-title":"Emerging drugs for lysosomal storage diseases","volume":"15","author":"Beck","year":"2010","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0380","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1182\/blood.V3.11.1221.1221","article-title":"Adult Gaucher's disease, with special reference to the variations in its clinical course and the value of sternal puncture as an aid to its diagnosis","volume":"3","author":"Groen","year":"1948","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0340","first-page":"278","article-title":"Gaucher's disease and acute leukemia","volume":"28","author":"Gelfand","year":"1961","journal-title":"J. Mt. Sinai Hosp. N. Y."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0235","first-page":"673","article-title":"Gaucher's disease associated with a cerebral astrocytoma. A case report involving an adult","volume":"12","author":"Davis","year":"1961","journal-title":"Am. Pract. Dig. Treat."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0610","first-page":"537","article-title":"Coincidence of multiple myeloma with Gaucher's disease","volume":"1","author":"Pinkhas","year":"1965","journal-title":"Isr. J. Med. Sci."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0635","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1182\/blood.V31.5.633.633","article-title":"Immunoglobulin abnormalities in Gaucher's disease. Report of 16 cases","volume":"31","author":"Pratt","year":"1968","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/path.1711160403","article-title":"Gaucher's disease associated with chronic lymphocytic leukaemia, gout and carcinoma","volume":"116","author":"Chang-Lo","year":"1975","journal-title":"J. Pathol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0115","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.1977.03270500081038","article-title":"Gaucher's disease in an asymptomatic 72-year-old","volume":"237","author":"Beutler","year":"1977","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0275","first-page":"460","article-title":"Amyloidosis. An unusual complication of Gaucher's disease","volume":"102","author":"Dikman","year":"1978","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0390","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/0003-4819-89-5-639","article-title":"Primary amyloidosis associated with Gaucher's disease","volume":"89","author":"Hanash","year":"1978","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1600-0609.1979.tb00419.x","article-title":"Nonsecretory IgD-kappa multiple myeloma in a patient with Gaucher's disease","volume":"22","author":"Benjamin","year":"1979","journal-title":"Scand. J. Haematol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0450","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0609.1979.tb02681.x","article-title":"Acute leukaemia and Gaucher's disease","volume":"23","author":"Krause","year":"1979","journal-title":"Scand. J. Haematol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0660","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archinte.1980.00330190127042","article-title":"Coexistence of IgA myeloma and Gaucher's disease","volume":"140","author":"Ruestow","year":"1980","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0190","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00000441-196709000-00005","article-title":"Gaucher's disease. Review of the literature and report of twelve new cases","volume":"254","author":"Chang-Lo","year":"1967","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0520","first-page":"122","article-title":"Multiple myeloma complicating Gaucher's disease","volume":"136","author":"Miller","year":"1982","journal-title":"West. J. Med."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0720","first-page":"388","article-title":"Gaucher's disease: a disease with chronic stimulation of the immune system","volume":"106","author":"Shoenfeld","year":"1982","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0320","first-page":"63","article-title":"Sequential appearance of breast carcinoma, multiple myeloma and Gaucher's disease","volume":"73","author":"Gal","year":"1988","journal-title":"Haematologica"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0360","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0009-9260(88)80559-2","article-title":"Nodular sclerosing Hodgkin's disease in association with Gaucher's disease","volume":"39","author":"Goodman","year":"1988","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0210","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/pgmj.63.744.899","article-title":"Adult Gaucher disease in association with acute leukaemia","volume":"63","author":"Corbett","year":"1987","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0155","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1600-0609.1985.tb02269.x","article-title":"Association of Gaucher's disease and lymphoid malignancy in 2 children","volume":"35","author":"Burstein","year":"1985","journal-title":"Scand. J. Haematol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0495","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ajh.2830290403","article-title":"Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease","volume":"29","author":"Marti","year":"1988","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0445","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/1097-0142(19830215)51:4<712::AID-CNCR2820510426>3.0.CO;2-6","article-title":"Association of dysgerminoma and Gaucher's disease","volume":"51","author":"Kojiro","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0715","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/1097-0142(19930701)72:1<219::AID-CNCR2820720139>3.0.CO;2-Y","article-title":"Increased risk of cancer in patients with Gaucher disease","volume":"72","author":"Shiran","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2005.08.004","article-title":"Increased incidence of cancer in adult Gaucher disease in Western Europe","volume":"36","author":"de Fost","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0765","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ajh.21362","article-title":"The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients","volume":"84","author":"Taddei","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0200","doi-asserted-by":"crossref","first-page":"150450","DOI":"10.1155\/2011\/150450","article-title":"Gaucher disease and cancer: concept and controversy","volume":"2011","author":"Choy","year":"2011","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0655","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2004-12-4672","article-title":"Gaucher disease and cancer incidence: a study from the Gaucher Registry","volume":"105","author":"Rosenbloom","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0895","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bcmd.2005.03.004","article-title":"Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic","volume":"34","author":"Zimran","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0465","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ijc.20097","article-title":"Cancer mortality in Europe, 1995\u20131999, and an overview of trends since 1960","volume":"110","author":"Levi","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0650","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/GIM.0b013e318195e2b6","article-title":"Multiple myeloma and Gaucher genes","volume":"11","author":"Rosenbloom","year":"2009","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0890","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ajh.21369","article-title":"Enzyme replacement therapy for mild patients with Gaucher disease","volume":"84","author":"Zimran","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0060","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/bjh.12335","article-title":"Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature","volume":"161","author":"Arends","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10","volume":"90","author":"Allen","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0410","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/bcmd.1997.0137","article-title":"Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease","volume":"23","author":"Hollak","year":"1997","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0255","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00277-008-0441-8","article-title":"Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature","volume":"87","author":"de Fost","year":"2008","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bcmd.2003.10.007","article-title":"Effect of enzyme replacement therapy on gammopathies in Gaucher disease","volume":"32","author":"Brautbar","year":"2004","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0855","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MPH.0b013e31806451d3","article-title":"Hyperimmunoglobulinemia in pediatric-onset type 1 Gaucher disease and effects of enzyme replacement therapy","volume":"29","author":"Wine","year":"2007","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0540","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson's syndrome in type I Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0780","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mgme.2001.3201","article-title":"Gaucher disease and parkinsonism: a phenotypic and genotypic characterization","volume":"73","author":"Tayebi","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0785","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","article-title":"Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?","volume":"79","author":"Tayebi","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0810","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ajmg.a.10028","article-title":"Gaucher disease associated with parkinsonism: four further case reports","volume":"116A","author":"V\u00e1rkonyi","year":"2003","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0480","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","article-title":"Glucocerebrosidase mutations in subjects with parkinsonism","volume":"81","author":"Lwin","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0030","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa033277","article-title":"Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews","volume":"351","author":"Aharon-Peretz","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0695","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mds.20319","article-title":"Analysis of the glucocerebrosidase gene in Parkinson's disease","volume":"20","author":"Sato","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0285","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/mds.20766","article-title":"Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela","volume":"21","author":"Eblan","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0795","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1212\/01.wnl.0000196492.80676.7c","article-title":"Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population","volume":"66","author":"Toft","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0205","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.wnl.0000276989.17578.02","article-title":"Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease","volume":"69","author":"Clark","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0770","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/archneur.64.7.1056","article-title":"Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients","volume":"64","author":"Tan","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0875","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/jnnp.2006.105940","article-title":"Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese","volume":"78","author":"Wu","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0885","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ymgme.2007.03.004","article-title":"Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease","volume":"91","author":"Ziegler","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0140","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.neurobiolaging.2007.11.016","article-title":"Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal","volume":"30","author":"Bras","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0325","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.wnl.0000304039.11891.29","article-title":"Genotype\u2013phenotype correlations between GBA mutations and Parkinson disease risk and onset","volume":"70","author":"Gan-Or","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0750","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.parkreldis.2007.06.010","article-title":"Association between Parkinson's disease and glucocerebrosidase mutations in Brazil","volume":"14","author":"Spitz","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0500","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneurol.2007.68","article-title":"Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders","volume":"65","author":"Mata","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0265","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/mds.21892","article-title":"Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy","volume":"23","author":"De Marco","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0555","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/01.wnl.0000327823.81237.d1","article-title":"Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset","volume":"72","author":"Nichols","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0545","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0525","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archneurol.2009.72","article-title":"Mutations for Gaucher disease confer high susceptibility to Parkinson disease","volume":"66","author":"Mitsui","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0425","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neulet.2009.01.029","article-title":"Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece","volume":"452","author":"Kalinderi","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0730","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1212\/WNL.0b013e3181b28601","article-title":"Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset","volume":"73","author":"Sidransky","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0595","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00415-013-6923-1","article-title":"Parkinsonism, dementia and glucocerebrosidase mutations","volume":"260","author":"Peall","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0880","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ymgme.2010.12.014","article-title":"Accumulation and distribution of \u03b1-synuclein and ubiquitin in the CNS of Gaucher disease mouse models","volume":"102","author":"Xu","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0145","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1111\/j.1742-4658.2008.06709.x","article-title":"Emerging pathways in genetic Parkinson's disease: potential role of ceramide metabolism in Lewy body disease","volume":"275","author":"Bras","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0355","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-010-0741-7","article-title":"Glucocerebrosidase is present in \u03b1-synuclein inclusions in Lewy body disorders","volume":"120","author":"Goker-Alpan","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0225","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0435","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tcb.2012.05.006","article-title":"Chaperone-mediated autophagy: a unique way to enter the lysosome world","volume":"22","author":"Kaushik","year":"2012","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0485","doi-asserted-by":"crossref","first-page":"13621","DOI":"10.1074\/jbc.M109.074617","article-title":"Lysosomal degradation of alpha-synuclein in vivo","volume":"285","author":"Mak","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0045","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","article-title":"Chaperone-mediated autophagy markers in Parkinson disease brains","volume":"67","author":"Alvarez-Erviti","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0840","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molmed.2011.05.003","article-title":"Exploring the link between glucocerebrosidase mutations and parkinsonism","volume":"17","author":"Westbroek","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0230","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid \u03b2-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter \u03b1-synuclein processing","volume":"69","author":"Cullen","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0415","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymgme.2011.07.002","article-title":"The enigma of the E326K mutation in acid \u03b2-glucocerebrosidase","volume":"104","author":"Horowitz","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0580","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.22687","article-title":"PD GWAS Consortium. Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2","volume":"71","author":"Pankratz","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0280","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/mds.25248","article-title":"The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease","volume":"28","author":"Duran","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0585","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1034\/j.1399-0004.2002.610106.x","article-title":"The E326K mutation and Gaucher disease: mutation or polymorphism?","volume":"61","author":"Park","year":"2002","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0470","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ymgme.2011.12.002","article-title":"Is E326K glucocerebrosidase a polymorphic or pathological variant?","volume":"105","author":"Liou","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0530","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20043","article-title":"Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: pathogenic changes and \u201cmodifier\u201d polymorphisms","volume":"23","author":"Montfort","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0490","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ejhg.2013.182","article-title":"Functional analysis of 11 novel GBA alleles","volume":"22","author":"Malini","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0865","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neulet.2011.05.238","article-title":"Genetic analysis of lysosomal alpha-galactosidase A gene in sporadic Parkinson's disease","volume":"500","author":"Wu","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0850","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/mds.24029","article-title":"Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome","volume":"27","author":"Winder-Rhodes","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0330","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1212\/WNL.0b013e31828f180e","article-title":"The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease","volume":"80","author":"Gan-Or","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0300","doi-asserted-by":"crossref","first-page":"2890.e13","DOI":"10.1016\/j.neurobiolaging.2013.06.010","article-title":"Rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson's disease","volume":"34","author":"Foo","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0430","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa0902630","article-title":"Mutations in the lysosomal enzyme-targeting pathway and persistent stuttering","volume":"362","author":"Kang","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0645","article-title":"Mucolipidosis types II and III and non-syndromic stuttering are associated with different variants in the same genes","author":"Raza","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0195","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12863-015-0172-5","article-title":"Association study of stuttering candidate genes GNPTAB, GNPTG and NAGPA with dyslexia in Chinese population","volume":"16","author":"Chen","year":"2015","journal-title":"BMC Genet."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0370","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2006-956755","article-title":"Frontotemporal dementia","volume":"27","author":"Graff-Radford","year":"2007","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0705","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp.2010.212225","article-title":"Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review","volume":"82","author":"Seelaar","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0735","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00401-012-1029-x","article-title":"The genetics and neuropathology of frontotemporal lobar degeneration","volume":"124","author":"Sieben","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0365","first-page":"845","article-title":"Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis","volume":"127","author":"G\u00f6tzl","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0745","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","article-title":"Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage","volume":"90","author":"Smith","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.neurobiolaging.2006.10.028","article-title":"A novel deletion in progranulin gene is associated with FTDP-17 and CBS","volume":"29","author":"Benussi","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2353\/ajpath.2010.090915","article-title":"Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging","volume":"177","author":"Ahmed","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0055","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0550","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0475","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbamcr.2008.09.018","article-title":"Proteomics of the lysosome","volume":"1793","author":"L\u00fcbke","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0510","first-page":"43","article-title":"Lysosomal storage diseases in Greece","volume":"6","author":"Michelakakis","year":"1995","journal-title":"Genet. Couns."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0455","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cell.2010.05.008","article-title":"Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations","volume":"141","author":"Lee","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0755","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1093\/brain\/awr250","article-title":"X-linked Angelman-like syndrome caused by Slc9a6 knockout in mice exhibits evidence of endosomal\u2013lysosomal dysfunction","volume":"134","author":"Str\u00f8mme","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0070","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.01192.x","article-title":"The neuropathogenic contributions of lysosomal dysfunction","volume":"83","author":"Bahr","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(90)90456-L","article-title":"Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin","volume":"513","author":"Cataldo","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0175","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0006-8993(94)91858-9","article-title":"Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease","volume":"640","author":"Cataldo","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0160","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0896-6273(95)90324-0","article-title":"Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal\u2013lysosomal system","volume":"14","author":"Cataldo","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0170","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1523\/JNEUROSCI.16-01-00186.1996","article-title":"Properties of the endosomal\u2013lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease","volume":"16","author":"Cataldo","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0535","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(91)90395-A","article-title":"Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease","volume":"130","author":"Nakamura","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0575","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1749-6632.1992.tb27478.x","article-title":"The lysosomal system in neurons. Involvement at multiple stages of Alzheimer's disease pathogenesis","volume":"674","author":"Nixon","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0570","series-title":"Alzheimer's Disease: Advances in Clinical and Basic Research","first-page":"441","article-title":"Abnormalities of lysosomal proteolysis in neurons in Alzheimer's disease and Down's syndrome: possible relationship to \u03b2-amyloid deposition","author":"Nixon","year":"1993"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0006-8993(94)91509-1","article-title":"An immunohistochemical study of cathepsin E in Alzheimer-type dementia brains","volume":"667","author":"Bernstein","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0165","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1523\/JNEUROSCI.17-16-06142.1997","article-title":"Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis","volume":"17","author":"Cataldo","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0515","series-title":"Lysosomal Storage Disorders \u2014 A Practical Guide","article-title":"The lysosomal system: physiology and pathology","author":"Micsenyi","year":"2012"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0690","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1073\/pnas.1108197108","article-title":"CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy","volume":"108","author":"Sardi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0270","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/mds.25462","article-title":"Lysosomal impairment in Parkinson's disease","volume":"28","author":"Dehay","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymgme.2015.08.008_bb0675","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nature12692","article-title":"Cancer: killing from the inside","volume":"502","author":"Saftig","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0440","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature08710","article-title":"Hsp70 stabilizes lysosomes and reverts Niemann\u2013Pick disease-associated lysosomal pathology","volume":"463","author":"Kirkegaard","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0600","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccr.2013.08.003","article-title":"Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase","volume":"24","author":"Petersen","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymgme.2015.08.008_bb0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jmcb\/mjt022","article-title":"The lysosome: from waste bag to potential therapeutic target","volume":"5","author":"Appelqvist","year":"2013","journal-title":"J. Mol. Cell Biol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719215300433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719215300433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T09:03:56Z","timestamp":1599469436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719215300433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":175,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1096719215300433"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2015.08.008","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From rare to common and back again: 60years of lysosomal dysfunction","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2015.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}